Kumar I Suresh, Kulkarni Rajendra G, Sahoo Dibyajyoti, Basavarajegowda Abhishekh
Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Asian J Transfus Sci. 2025 Jan-Jun;19(1):23-28. doi: 10.4103/ajts.ajts_112_22. Epub 2023 May 11.
Pretransfusion testing is an essential and important investigation to provide safe and fully compatible packed red blood cell (PRBC) unit to the recipient to prevent the fatal hemolytic transfusion reaction. Type and screen (T and S) procedure is one of the effective approaches in pretransfusion testing in which antibody screen (AS) negative recipients are transfused with an immediate saline phase compatible PRBC unit. In order to explore the feasibility of implementing T and S protocol in our institute, this study was carried out. The main aim of our study was to compare the T and S protocol in AS-negative recipients with anti-human globulin (AHG) phase crossmatch in patients requiring PRBC under elective protocol.
Our study was a cross-sectional analytical study carried out in all the elective blood samples with a history of transfusion or pregnancy. In our study, 849 elective blood samples were subjected to antibody screening by reagent 3 red cell screening panel and AS-negative blood samples were subjected to immediate saline phase crossmatch, and compatible units were issued to the patients. The same samples were subjected to AHG phase crossmatch for validation.
Among 14,705 elective requests for PRBC 849 patients had a history of transfusion or pregnancy. Of 849 patients, no case was found to be positive for antibody screening. Totally around 1028 PRBC units were saline crossmatched and totally 677 PRBC units were issued to the patients under T and S protocol. Not even a single case where AHG crossmatch was incompatible when antibody screening was negative. There was a perfect agreement between T and S method and AHG phase crossmatch. Crossmatch transfusion ratio was reduced from 2.1-1.5 with the implementation of T and S protocol.
This study validated and showed that there was a perfect agreement between T and S protocol and AHG phase crossmatch. All blood requests under elective protocol, the T and S method can be implemented for better utilization of technical workforce and better inventory management.
输血前检测是一项至关重要的调查,旨在为受血者提供安全且完全匹配的红细胞浓缩液(PRBC)单位,以预防致命的溶血性输血反应。血型鉴定和筛查(T和S)程序是输血前检测的有效方法之一,其中抗体筛查(AS)阴性的受血者会输注即刻盐水相匹配的PRBC单位。为了探讨在我院实施T和S方案的可行性,开展了本研究。我们研究的主要目的是比较在择期方案下需要PRBC的AS阴性受血者中T和S方案与抗人球蛋白(AHG)相交叉配血的情况。
我们的研究是一项横断面分析研究,对所有有输血或妊娠史的择期血样进行。在我们的研究中,849份择期血样通过试剂3红细胞筛查板进行抗体筛查,AS阴性血样进行即刻盐水相交叉配血,并向患者发放匹配的单位。对相同样本进行AHG相交叉配血以进行验证。
在14705份择期PRBC申请中,849名患者有输血或妊娠史。在849名患者中,未发现抗体筛查呈阳性的病例。总共约1028个PRBC单位进行了盐水交叉配血,在T和S方案下总共向患者发放了677个PRBC单位。当抗体筛查为阴性时,没有一例AHG交叉配血不相容的情况。T和S方法与AHG相交叉配血之间存在完美的一致性。随着T和S方案的实施,交叉配血输血率从2.1降至1.5。
本研究验证并表明T和S方案与AHG相交叉配血之间存在完美的一致性。对于所有择期方案下的血液申请,可实施T和S方法以更好地利用技术人员并进行更好的库存管理。